In advanced ovarian cancer, the overexpression of Src, a non-receptor tyrosine kinase, is notable, especially since inhibiting Src appears to overcome platinum resistance, partly by enhancing caspase-3-mediated apoptosis. Here, SRC is linked to ovarian carcinoma.